|
DK2134685T3
(en)
|
2007-04-16 |
2015-12-07 |
Abbvie Inc |
7-unsubstituted indole derivatives as MCL-1 inhibitors
|
|
CN102325531B
(zh)
|
2008-12-19 |
2014-04-02 |
健泰科生物技术公司 |
化合物和使用方法
|
|
US8628554B2
(en)
|
2010-06-13 |
2014-01-14 |
Virender K. Sharma |
Intragastric device for treating obesity
|
|
US10010439B2
(en)
|
2010-06-13 |
2018-07-03 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US10420665B2
(en)
|
2010-06-13 |
2019-09-24 |
W. L. Gore & Associates, Inc. |
Intragastric device for treating obesity
|
|
US9526648B2
(en)
|
2010-06-13 |
2016-12-27 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
|
KR101919080B1
(ko)
*
|
2011-05-20 |
2018-11-16 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
디아실글리세롤 아실트랜스퍼라제 억제제로서의 신규 화합물
|
|
US8889675B2
(en)
|
2011-10-14 |
2014-11-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
TWI561521B
(en)
*
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
CN103958508B
(zh)
*
|
2011-10-14 |
2019-02-12 |
艾伯维公司 |
用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂
|
|
TWI571466B
(zh)
*
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
|
JP5955531B2
(ja)
*
|
2011-11-07 |
2016-07-20 |
千葉県 |
抗癌剤
|
|
HUE042374T2
(hu)
|
2012-06-13 |
2019-06-28 |
Incyte Holdings Corp |
Szubsztituált triciklusos vegyületek mint FGFR inhibitorok
|
|
CN103515415A
(zh)
*
|
2012-06-26 |
2014-01-15 |
群康科技(深圳)有限公司 |
叠层结构与其制造方法、以及包含其的电子装置
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
MX360172B
(es)
|
2012-08-13 |
2018-10-12 |
Abbvie Inc |
Agentes que inducen la apoptosis.
|
|
JP6318156B2
(ja)
*
|
2012-09-06 |
2018-04-25 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼをモジュレートするための化合物および方法、ならびにその指標
|
|
MA38009B1
(fr)
*
|
2012-10-11 |
2018-09-28 |
Hoffmann La Roche |
Composes d'azaindoline substitues qui ont une activite inhibitrice de la proteine d'apoptose pour leurs utilisations dans le traitement et/ou la prophylaxie du cancer
|
|
US9796729B2
(en)
|
2012-11-23 |
2017-10-24 |
Glaxosmithkline Llc |
Compounds as diacylglycerol acyltransferase inhibitors
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
WO2014145852A2
(en)
|
2013-03-15 |
2014-09-18 |
Knopp Biosciences Llc |
Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
|
|
KR102469849B1
(ko)
|
2013-04-19 |
2022-11-23 |
인사이트 홀딩스 코포레이션 |
Fgfr 저해제로서 이환식 헤테로사이클
|
|
FR3008979B1
(fr)
*
|
2013-07-23 |
2015-07-24 |
Servier Lab |
Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR3008975A1
(fr)
|
2013-07-23 |
2015-01-30 |
Servier Lab |
Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
IL311537A
(en)
|
2014-01-28 |
2024-05-01 |
Mayo Found Medical Education & Res |
Methods and preparations for killing aging cells and for the treatment of diseases and disorders related to aging
|
|
EP3139942B1
(en)
|
2014-05-05 |
2019-12-18 |
Bioventures, Llc |
COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS
|
|
US10071087B2
(en)
|
2014-07-22 |
2018-09-11 |
Bioventures, Llc |
Compositions and methods for selectively depleting senescent cells
|
|
WO2016040952A2
(en)
|
2014-09-12 |
2016-03-17 |
Knopp Biosciences Llc |
BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
EP3230283A1
(en)
*
|
2014-12-09 |
2017-10-18 |
AbbVie Inc. |
Bcl-xl inhibitory compounds and antibody drug conjugates including the same
|
|
EP3230282A1
(en)
*
|
2014-12-09 |
2017-10-18 |
AbbVie Inc. |
Bcl xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same
|
|
WO2016131100A1
(en)
*
|
2015-02-18 |
2016-08-25 |
The Walter And Eliza Hall Institute Of Medical Research |
Methods of treating infectious diseases
|
|
AU2016219822B2
(en)
|
2015-02-20 |
2020-07-09 |
Incyte Holdings Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
US10195213B2
(en)
|
2015-03-13 |
2019-02-05 |
Unity Biotechnology, Inc. |
Chemical entities that kill senescent cells for use in treating age-related disease
|
|
WO2016172218A1
(en)
*
|
2015-04-20 |
2016-10-27 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of mcl-1 and uses thereof
|
|
AU2016315881B2
(en)
*
|
2015-09-03 |
2019-09-19 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of DYRK1A and uses thereof
|
|
SG11201804210XA
(en)
*
|
2015-11-20 |
2018-06-28 |
Mingsight Pharmaceuticals Inc |
Treatment of autoimmune disease
|
|
US10807977B2
(en)
|
2016-04-21 |
2020-10-20 |
Bioventures, Llc |
Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof
|
|
US10779980B2
(en)
|
2016-04-27 |
2020-09-22 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US10640563B2
(en)
|
2016-06-08 |
2020-05-05 |
Abbvie Inc. |
Anti-B7-H3 antibodies and antibody drug conjugates
|
|
WO2018029473A1
(en)
*
|
2016-08-09 |
2018-02-15 |
University Of Durham |
Synthetic retinoids (in cell modulation)
|
|
US20180072741A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyrimidine compounds and uses thereof
|
|
KR20230038807A
(ko)
|
2016-09-09 |
2023-03-21 |
인사이트 코포레이션 |
Hpk1 조절제로서의 피라졸로피리딘 유도체 및 암의 치료를 위한 이의 용도
|
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
|
WO2018092064A1
(en)
*
|
2016-11-18 |
2018-05-24 |
Novartis Ag |
Combinations of mdm2 inhibitors and bcl-xl inhibitors
|
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
CN108186642B
(zh)
*
|
2018-01-11 |
2019-11-08 |
广西师范大学 |
一种协同起作用治疗肺癌的药物组合物
|
|
ES3041854T3
(en)
|
2018-01-22 |
2025-11-17 |
Bioventures Llc |
Bcl-2 proteins degraders for cancer treatment
|
|
HUE059624T2
(hu)
|
2018-02-20 |
2022-11-28 |
Incyte Corp |
N-(fenil)-2-(fenil)pirimidin-4-karboxamid származékok és rokon vegyületek HPK1-inhibitorokként rák kezelésére
|
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
IL277419B2
(en)
|
2018-03-19 |
2024-07-01 |
Knopp Biosciences Llc |
Kv7 channel activators compositions and methods of use
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
EP4309737A3
(en)
|
2018-05-04 |
2024-03-27 |
Incyte Corporation |
Solid forms of an fgfr inhibitor and processes for preparing the same
|
|
EP3788046B1
(en)
|
2018-05-04 |
2025-12-10 |
Incyte Corporation |
Salts of an fgfr inhibitor
|
|
US12084423B2
(en)
|
2018-05-18 |
2024-09-10 |
Bioventures, Llc |
Piperlongumine analogues and uses thereof
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
WO2020068729A1
(en)
|
2018-09-25 |
2020-04-02 |
Incyte Corporation |
Pyrazolo[4,3-d]pyrimidine compounds as alk2 abd/or fgfr modulators
|
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
AR119494A1
(es)
*
|
2019-07-29 |
2021-12-22 |
Servier Lab |
DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS
|
|
PH12022550271A1
(en)
|
2019-08-06 |
2023-06-26 |
Incyte Corp |
Solid forms of an hpk1 inhibitor
|
|
US12122767B2
(en)
|
2019-10-01 |
2024-10-22 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021076602A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
KR20220131900A
(ko)
|
2019-12-04 |
2022-09-29 |
인사이트 코포레이션 |
Fgfr 억제제의 유도체
|
|
JP7720840B2
(ja)
|
2019-12-04 |
2025-08-08 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤としての三環式複素環
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CN112079791A
(zh)
*
|
2020-08-21 |
2020-12-15 |
宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） |
单环β-内酰胺类抗生素侧链酸及其酯、其制备方法和应用
|
|
EP4251209A1
(en)
|
2020-11-24 |
2023-10-04 |
Novartis AG |
Bcl-xl inhibitor antibody-drug conjugates and methods of use thereof
|
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
IL304891A
(en)
|
2021-02-02 |
2023-10-01 |
Servier Lab |
Selective Protech BCL-XL compounds and methods of use
|
|
CA3215903A1
(en)
|
2021-04-12 |
2022-10-20 |
Incyte Corporation |
Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
|
|
KR102605163B1
(ko)
*
|
2021-06-01 |
2023-11-23 |
연세대학교 산학협력단 |
뇌암의 예방 또는 치료용 조성물
|
|
EP4352059A1
(en)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
WO2022261159A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
CN114294905B
(zh)
*
|
2021-11-19 |
2023-04-25 |
中粮生物科技股份有限公司 |
利用红外或微波干燥聚羟基脂肪酸酯的方法
|
|
IL317103A
(en)
|
2022-05-20 |
2025-01-01 |
Novartis Ag |
Antibody-drug conjugates of MET inhibitor BCL-XL and methods of using them
|
|
KR20250027285A
(ko)
|
2022-05-20 |
2025-02-25 |
노파르티스 아게 |
항신생물 화합물의 항체-약물 접합체 및 그의 사용 방법
|
|
EP4525925A1
(en)
|
2022-05-20 |
2025-03-26 |
Novartis AG |
Epha2 bcl-xl inhibitor antibody-drug conjugates and methods of use thereof
|
|
WO2024036961A1
(zh)
*
|
2022-08-19 |
2024-02-22 |
北京三秀生物医药科技有限公司 |
一种抗衰老相关疾病的前药及其使用方法
|
|
WO2025111450A1
(en)
|
2023-11-22 |
2025-05-30 |
Les Laboratoires Servier |
Anti-cd74 antibody-drug conjugates and methods of use thereof
|
|
WO2025111431A1
(en)
|
2023-11-22 |
2025-05-30 |
Les Laboratoires Servier |
Anti-cd7 antibody-drug conjugates and methods of use thereof
|
|
TW202527945A
(zh)
*
|
2023-12-18 |
2025-07-16 |
大陸商南京瑞初醫藥有限公司 |
氮雜環化合物及其應用
|